Porosome Therapeutics, Inc. — Form D/A
Porosome Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2026-03-24. $3.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-24
- Form: D/A
- Accession: 0001376474-26-000247
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $3.6M
- Minimum investment: $50K
- Investors: 7
- Date of first sale: 2023-09-08
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-492097
Issuer
- Name: Porosome Therapeutics, Inc.
- CIK: 0001934919
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: ONE BOSTON PLACE, STE 2631, BOSTON, MA, 02108
- Phone: 781 956 9799
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Guillermo Marmol | Related Person | Boston, MA |
| Guillermo Marmol | Executive Officer | Boston, MA |
Other filings by this issuer (4)
More